20-Bio-A3 Biomechanics · December 2018
Nivaar worked solution (AI-drafted; not reviewed by a licensed engineer)
National Exams — December 2018 — 04-Bio-A3, Cellular and Molecular Biology and Biochemistry. Three-hour, CLOSED-BOOK exam; only an approved Casio or Sharp calculator is permitted. The paper carries six questions of equal value (20 marks each): FIVE questions constitute a complete paper and only the first five as they appear in the answer book are marked (100 marks total), with candidates urged to state any interpretive assumptions in writing. All SIX questions are worked below as a complete study resource. Question 6 is a 20-item True/False set marked +1 for a correct answer, 0 for a blank, and −1 for an incorrect answer.
Reference texts: Alberts et al., Molecular Biology of the Cell (6th ed.) — cell structure, gene regulation, DNA/RNA/protein synthesis; Nelson & Cox, Lehninger Principles of Biochemistry (7th ed.) — enzyme kinetics, Michaelis–Menten and substrate inhibition; Sambrook & Russell, Molecular Cloning: A Laboratory Manual (4th ed.) — restriction mapping, Sanger sequencing; Murphy & Weaver, Janeway's Immunobiology (9th ed.) — antibody structure and function; Murray et al., Medical Microbiology (9th ed.) — antibiotic mechanisms and susceptibility testing.
Question text not reproduced: the examination questions are © Engineers and Geoscientists BC. Open the official past paper (linked at the top of this page) to read the question, then follow the worked solution below.
(a) An allosteric protein is one whose activity or conformation is controlled by the binding of a small effector molecule (an activator or inhibitor, sometimes the substrate itself) at a regulatory site that is physically distinct from the protein's primary functional site (e.g. the catalytic active site of an enzyme, or the DNA-binding site of a transcription factor). Effector binding induces a conformational change — a shift between alternative three-dimensional shapes — that is transmitted through the protein's structure to the distant functional site, switching its activity on or off (or tuning it up or down) without any covalent modification of the protein itself. Because the effector-binding event and the functional output are coupled purely through this shape change, allosteric regulation gives the cell a fast, reversible, and often cooperative (sigmoidal, switch-like) way to sense a small-molecule signal and translate it into a change in protein function — classic examples include hemoglobin's cooperative O2 binding, feedback-inhibited metabolic enzymes, and DNA-binding regulatory proteins such as the lac repressor discussed below.
(b) A transcriptional repressor is a DNA-binding protein that, in its default (unliganded) conformation, binds tightly and specifically to an operator sequence overlapping or adjacent to a promoter, physically blocking RNA polymerase from initiating (or elongating) transcription of the downstream gene(s). When this repressor is also allosteric, a small-molecule effector (an inducer) can bind a site distinct from the DNA-binding domain and trigger a conformational change that lowers the repressor's affinity for the operator, causing it to dissociate from the DNA and de-repress transcription. The lac repressor (LacI) is the canonical example: in the absence of lactose, LacI's DNA-binding domain clamps onto the lac operator, keeping the lacZYA genes off; when lactose is present, a small amount is converted to allolactose, which binds an allosteric site on LacI, changes its conformation, and reduces its operator affinity so it releases the DNA, allowing RNA polymerase to transcribe the operon. The protein's function as a repressor is thus entirely dependent on its allosteric behaviour — the same polypeptide is a tight DNA binder or a poor one, purely as a function of which conformation the effector has selected.
(c) cAMP controls lac transcription through a second, independent regulatory protein: catabolite activator protein (CAP, also called CRP). CAP is itself allosteric — it only binds DNA efficiently when cAMP is bound to it. Intracellular cAMP concentration is inversely linked to glucose availability: when glucose is scarce, adenylate cyclase activity rises and cAMP accumulates; when glucose is abundant, cAMP stays low. High cAMP produces the active cAMP–CAP complex, which binds a specific CAP site just upstream of the lac promoter and helps recruit and stabilize RNA polymerase there, substantially increasing (activating) transcription initiation. When glucose is plentiful, cAMP is low, little cAMP–CAP complex forms, and the lac promoter (which is intrinsically weak) is transcribed only poorly even if the repressor has been removed by lactose — this is catabolite repression. The lac operon is therefore under dual control: the repressor/operator system (part b) is a binary NOT-lactose-present switch, while the cAMP–CAP system is an analog amplifier that only permits strong transcription when the preferred carbon source (glucose) is absent, so the cell preferentially uses glucose and only fully commits to lactose metabolism when glucose is unavailable AND lactose is present.
(d) β-galactosidase is an excellent reporter because its enzymatic activity is easy, fast, cheap, and quantitative to detect: it hydrolyzes a variety of synthetic chromogenic and fluorogenic substrates that are colourless (or non-fluorescent) until cleaved, producing an intense, easily measured colour or fluorescent/luminescent signal — for example X-gal is cleaved to an insoluble blue precipitate (used for blue/white colony screening) and ONPG is cleaved to a yellow soluble product whose absorbance can be read spectrophotometrically for quantitative assays. Because the signal is produced only when the enzyme is expressed and active, the amount of colour produced is a direct, quantifiable proxy for the activity of whatever promoter or regulatory element has been fused to the lacZ gene, and the assay works reliably in bacteria, yeast, and many other host systems, requires no specialized equipment for a simple visual readout, and the enzyme itself is robust and well characterized. This makes β-galactosidase (encoded by lacZ) one of the most widely used reporter genes for studying promoter activity, gene regulation, and successful cloning/transformation events.
(e) The lac regulatory DNA sequences (the promoter and operator) are themselves reused as a biotechnology tool: because they form a well-characterized, tightly controllable ON/OFF switch, they are cloned into expression vectors immediately upstream of a gene of interest to build inducible expression systems. In such a vector, the recombinant gene is transcriptionally silent (repressed by LacI, which is also supplied, often from a compatible plasmid or the host chromosome) until the experimenter adds an inducer — typically IPTG, a non-metabolizable structural analog of allolactose that binds and inactivates LacI without being hydrolyzed by β-galactosidase, giving stable, dose-controllable induction. This lets a researcher grow host cells (commonly E. coli) to a desired density before switching on expression of a potentially toxic or growth-inhibiting recombinant protein, maximizing yield. The same operator/promoter region, fused upstream of lacZ itself, is also the basis of blue/white screening in molecular cloning: a functional lacZα fragment (under lac promoter control) turns colonies blue on X-gal plates, while successful insertion of a cloned fragment into the multiple cloning site (which lies within lacZα) disrupts the reading frame and leaves colonies white, providing a simple visual screen for recombinant clones.